December 2025

KEYNOTE-B15, also known as EV-304, is an open-label, randomized Phase 3 trial evaluating perioperative KEYTRUDA in combination with Padcev and surgery (radical cystectomy and pelvic lymph node dissection) versus neoadjuvant chemotherapy and surgery in patients with MIBC who are cisplatin-eligible.

The U.S. Food and Drug Administration (FDA) has granted approval to RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), marking a significant advancement in the treatment of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer

D.Pharm, Registration with MSPC / PCI Council is mandatory, preference will be given to candidates with experience.

Pharmacist with Diploma in Integrated Pharmacy with Computer Knowledge including MS Office, MS word, MS Power Point and MS Excel, MS access would be essential.

Diploma/ Certificate course in Ayurvedic pharmacy conducted by the Paschim Banga Ayurved Parishad. Computer knowledge including MS Officers Word, MS Excel, MS Power point) & Internet.

10 + 2 plus 2 years Diploma in Pharmacy. Registration with State Pharmacy Council.

Pharm.D or M.Pharm (Pharmacy Practice] with State Pharmacy Council registration. Prior Clinical Pharmacist experience.

Doctoral degree in science / Engineering / Technology / Pharma / MD / MS from a recognized University or equivalent. 

Post-graduate degree in Life Sciences / Biotechnology / Bioinformatics or equivalent with minimum 60% marks.